Photo from Alfredo Rivas-Delgado/X
Apr 29, 2024, 00:54
Alfredo Rivas-Delgado: Review on treating high-risk MCL patients by Anita Kumar
Alfredo Rivas-Delgado, Research Fellow at Memorial Sloan Kettering Cancer, posted on X/Twitter:
“A comprehensive review on treating high-risk MCL patients by Anita Kumar
– High Ki67, TP53mut, blastoid morphology, POD24
– Targeted therapy including BTKi + BCL2inh + antiCD20
– Promising data with CAR-T and BsAbs
– Refer early to tertiary centers.“
Source: Alfredo Rivas-Delgado/X
May 15, 2024, 11:19
May 15, 2024, 11:05
May 15, 2024, 10:55
May 15, 2024, 10:54